Imagen de Portada

Editorial: Timely Follow‐Up in Cirrhosis: How Does It Work?

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Nina Kimer, Lise Lotte Gluud
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Alimentary Pharmacology & Therapeutics
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Editorial: Safety and Effects of Direct Oral Anticoagulants for Portal Vein Thrombosis
por: Nina Kimer, et al.
Publicado: (2025)

Letter: Timely Follow‐Up in Cirrhosis—A Key Public Health Intervention
por: Mo‐Yao Tan, et al.
Publicado: (2024)

Timely Follow‐Up After a First Diagnosis of Cirrhosis is Associated With Reduced Mortality but No Impact on Rehospitalisations: A Population‐Based Cohort of 8852 Patients
por: Max S. Schechter, et al.
Publicado: (2024)

Editorial: Navigating the Beta‐Blocker Dilemma in Advanced Liver Cirrhosis—When Is the Right Time to Discontinue?
por: Louise J. M. Alferink, et al.
Publicado: (2024)

Editorial: Diabetes Management in Cirrhosis—The Window of Opportunity Before Decompensation
por: Thanawin Pramotedham, et al.
Publicado: (2026)

Editorial: Navigating the Beta‐Blocker Dilemma in Advanced Liver Cirrhosis—When Is the Right Time to Discontinue? Authors' Reply
por: Ting Wang, et al.
Publicado: (2024)

Editorial: Statin Therapy in Cirrhosis: More Than Just Lipid‐Lowering
por: Emily Stephenson, et al.
Publicado: (2026)

Editorial: Linking Patients With Cirrhosis to Clinical Care—The Hurdles and Way Forward
por: Jimmy Che‐To Lai, et al.
Publicado: (2026)

Editorial: Polypharmacy in MASLD—An Overlooked Epidemic Disproportionately Affecting Women and Patients With Cirrhosis
por: Mary Yue Wang, et al.
Publicado: (2025)

Editorial: Redefining Decompensation in Cirrhosis—More Than an Academic Playground? Authors' Reply
por: Lucie Simonis, et al.
Publicado: (2025)

Editorial: Diabetes Management in Cirrhosis—The Window of Opportunity Before Decompensation. Authors' Reply
por: Mary Yue Wang, et al.
Publicado: (2026)

Editorial: ABID‐LSM–A Promising Model for Predicting Decompensation Risk in MASLD Cirrhosis
por: Eduardo Vilar‐Gomez, et al.
Publicado: (2025)

Editorial: Caught in the Middle—Exploring the Grey Zone Between Decompensated and Recompensated HBV ‐Related Cirrhosis
por: Stephanie Tsai, et al.
Publicado: (2025)

Refining Prognosis in Cirrhosis Patients With Ascites: Impact of Acute vs. Non‐Acute Decompensation
por: Lucie Simonis, et al.
Publicado: (2025)

Editorial: Caught in the Middle—Exploring the Grey Zone Between Decompensated and Recompensated HBV ‐Related Cirrhosis. Authors' Reply
por: Bingqiong Wang, et al.
Publicado: (2025)

Editorial: Decoding Gut Failure in Cirrhosis—Villin‐1 and the Emergence of a Seventh Organ Failure. Authors' Reply
por: David Tornai, et al.
Publicado: (2026)

Barriers to Medical Care Are Frequently Reported by Patients With Cirrhosis
por: William Chai, et al.
Publicado: (2025)

Letter: The Unresolved Issue of NSBB Confounding in Statin Research for Cirrhosis
por: Deliang Huang, et al.
Publicado: (2026)

Persistence of Symptoms of Anxiety and Depression in Inflammatory Bowel Disease: A Longitudinal Follow‐Up Study
por: Christy Riggott, et al.
Publicado: (2025)

Amino Acid Imbalance Is an Independent Factor for Mortality in Patients With Liver Cirrhosis
por: Yuki Utakata, et al.
Publicado: (2026)

Unstable Recompensation: An Intermediate Subtype in Patients With HBV ‐Related Decompensated Cirrhosis
por: Shuai Xia, et al.
Publicado: (2025)

Editorial: Cumulative Impact of Clinical Disease Activity, Biochemical Activity and Psychological Health on the Natural History of Inflammatory Bowel Disease During 8 Years of Longitudinal Follow‐Up
por: Ben Massouridis, et al.
Publicado: (2025)

Differential Characteristics and Survival Outcomes of Patients With Cirrhosis According to Underlying Liver Aetiology
por: Yu Shi, et al.
Publicado: (2025)

Letter: Amino Acid Imbalance Is an Independent Factor for Mortality in Patients With Liver Cirrhosis
por: Zhanbo Qu
Publicado: (2026)

Letter on: ‘Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPS ’
por: Sai Kiran Kuchana, et al.
Publicado: (2026)

Letter: Amino Acid Imbalance and Mortality in Cirrhosis—Interpretation and Methodological Considerations. Authors' Reply
por: Yuki Utakata, et al.
Publicado: (2026)

Systematic Review: Imaging‐Based Morphological Criteria for Liver Cirrhosis—A Call to Standardise
por: Mei Chin Lim, et al.
Publicado: (2026)

Meta‐Analysis: Global Prevalence and Mortality of Cirrhosis in Metabolic Dysfunction‐Associated Steatotic Liver Disease
por: Soroor Owrangi, et al.
Publicado: (2024)

Assessing Major Adverse Liver Outcomes With Baclofen Compared to Acamprosate in Compensated Alcohol‐Associated Cirrhosis
por: Yee Hui Yeo, et al.
Publicado: (2026)

Letter: Pharmacotherapy for Alcohol Dependence in Cirrhosis—By Addressing One Issue Do We Create Another?
por: Andrew W. Nguyen, et al.
Publicado: (2026)

Letter: Statins for Cirrhosis: Are We Ready to Move From Cardiovascular Prophylaxis to Portal Pressure Management?
por: Abdulrahman Ismaiel
Publicado: (2026)

Frailty Is Associated With All‐Cause and Acute Hospitalisations During 18 Months Follow‐Up in Older Patients With Inflammatory Bowel Disease
por: Anne B. Fons, et al.
Publicado: (2026)

Long‐Term Follow‐Up of Patients in a Prospective Study of NA Discontinuation Identifies Different Patterns of HBsAg Loss
por: Simon J. Hume, et al.
Publicado: (2025)

Emerging Trends in Patients Hospitalised With Cirrhosis—Aetiologies, Complications and Outcomes Compared to Other Chronic Health Conditions
por: Julian Pohl, et al.
Publicado: (2025)

Letter on: ‘Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPS ’. Authors' Reply
por: Christian Labenz, et al.
Publicado: (2026)

Patient Plasma‐Induced Neutrophil Dysfunction Is Associated With Infection Risk and Mortality in Patients With Acute Decompensation of Cirrhosis
por: Supachaya Sriphoosanaphan, et al.
Publicado: (2025)

Editorial: Resecting Assumptions—Do Proctocolectomy Guidelines Hold Up? Author's Reply
por: Erik Lundqvist, et al.
Publicado: (2025)

Spontaneous Bacterial Peritonitis Is Associated With High Mortality, Which Interacts With Antibiotic Prophylaxis in a National Cirrhosis Cohort
por: Scott Silvey, et al.
Publicado: (2025)

Correction to ‘Risk of Hepatocellular Cancer in U.S. Patients With Compensated Cirrhosis Treated With Direct‐Acting Antivirals Versus Interferon’
Publicado: (2025)

Letter: Statins for Cirrhosis: Are we Ready to Move From Cardiovascular Prophylaxis to Portal Pressure Management? Authors' Reply
por: Bernardo de Faria Moraes, et al.
Publicado: (2026)